371 related articles for article (PubMed ID: 33895215)
1. Next generation strategies for preventing preterm birth.
Zierden HC; Shapiro RL; DeLong K; Carter DM; Ensign LM
Adv Drug Deliv Rev; 2021 Jul; 174():190-209. PubMed ID: 33895215
[TBL] [Abstract][Full Text] [Related]
2. A chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth.
Nelson DB; McIntire DD; Leveno KJ
Am J Obstet Gynecol; 2021 Feb; 224(2):175-186. PubMed ID: 33035472
[TBL] [Abstract][Full Text] [Related]
3. Utilization of hydroxyprogesterone caproate among pregnancies with live birth deliveries in the sentinel distributed database.
Shinde M; Cosgrove A; Woods CM; Chang C; Nguyen CP; Moeny D; Ajao A; Kolonoski J; Tsai HT
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6291-6296. PubMed ID: 33926341
[TBL] [Abstract][Full Text] [Related]
4. Rationale for current and future progestin-based therapies to prevent preterm birth.
Weatherborn M; Mesiano S
Best Pract Res Clin Obstet Gynaecol; 2018 Oct; 52():114-125. PubMed ID: 29724668
[TBL] [Abstract][Full Text] [Related]
5. FDA approved vs. Pharmacy compounded 17-OHPC-current issues for obstetricians to consider in reducing recurrent preterm birth.
Gandell DL; Randell MD; Gudeman JL
Curr Med Res Opin; 2020 Aug; 36(8):1393-1401. PubMed ID: 32544354
[TBL] [Abstract][Full Text] [Related]
6. PROLONG Clinical Study Protocol: Hydroxyprogesterone Caproate to Reduce Recurrent Preterm Birth.
Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck T; Miller HS; Das AF; Birch R; Jozwiakowski MJ
Am J Perinatol; 2018 Oct; 35(12):1228-1234. PubMed ID: 29702708
[TBL] [Abstract][Full Text] [Related]
7. Accelerated Approval of 17α-Hydroxyprogesterone Caproate: A Cautionary Tale.
Godlewski BJ; Sobolik LI; King VJ; Harrod CS
Obstet Gynecol; 2020 May; 135(5):1207-1213. PubMed ID: 32282587
[TBL] [Abstract][Full Text] [Related]
8. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
[TBL] [Abstract][Full Text] [Related]
9. Vaginal compared with intramuscular progestogen for preventing preterm birth in high-risk pregnant women (VICTORIA study): a multicentre, open-label randomised trial and meta-analysis.
Choi SJ; Kwak DW; Kil K; Kim SC; Kwon JY; Kim YH; Na S; Bae JG; Cha HH; Shim JY; Oh KY; Lee KA; Kim SM; Cho IA; Lee SM; Cho GJ; Jo YS; Choi GY; Choi SK; Hur SE; Hwang HS; Kim YJ;
BJOG; 2020 Dec; 127(13):1646-1654. PubMed ID: 32536019
[TBL] [Abstract][Full Text] [Related]
10. 17 α-hydroxyprogesterone caproate (Makena®): a guide to its use in the prevention of preterm birth.
Hines M; Lyseng-Williamson KA; Deeks ED
Clin Drug Investig; 2013 Mar; 33(3):223-7. PubMed ID: 23413110
[TBL] [Abstract][Full Text] [Related]
11. Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth.
Ning A; Vladutiu CJ; Dotters-Katz SK; Goodnight WH; Manuck TA
Am J Obstet Gynecol; 2017 Sep; 217(3):371.e1-371.e7. PubMed ID: 28526452
[TBL] [Abstract][Full Text] [Related]
12. Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth.
Zierden HC; Ortiz JI; DeLong K; Yu J; Li G; Dimitrion P; Bensouda S; Laney V; Bailey A; Anders NM; Scardina M; Mahendroo M; Mesiano S; Burd I; Wagner G; Hanes J; Ensign LM
Sci Transl Med; 2021 Jan; 13(576):. PubMed ID: 33441428
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth.
Alizadeh F; Mahmoudinia M; Mirteimoori M; Pourali L; Niroumand S
BMC Pregnancy Childbirth; 2022 Mar; 22(1):167. PubMed ID: 35232423
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of progesterone for prevention of preterm birth.
Sykes L; Bennett PR
Best Pract Res Clin Obstet Gynaecol; 2018 Oct; 52():126-136. PubMed ID: 30266582
[TBL] [Abstract][Full Text] [Related]
15. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck TA; Miller HS; Das AF; Saade GR; Nielsen P; Baker J; Yuzko OM; Reznichenko GI; Reznichenko NY; Pekarev O; Tatarova N; Gudeman J; Birch R; Jozwiakowski MJ; Duncan M; Williams L; Krop J
Am J Perinatol; 2020 Jan; 37(2):127-136. PubMed ID: 31652479
[TBL] [Abstract][Full Text] [Related]
16. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V
Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
[TBL] [Abstract][Full Text] [Related]
17. Progestin therapy to prevent preterm birth: History and effectiveness of current strategies and development of novel approaches.
Mesiano SA; Peters GA; Amini P; Wilson RA; Tochtrop GP; van Den Akker F
Placenta; 2019 Apr; 79():46-52. PubMed ID: 30745115
[TBL] [Abstract][Full Text] [Related]
18. Unjustified increase in cost of care resulting from U.S. Food and Drug Administration approval of Makena (17α-hydroxyprogesterone caproate).
Cohen AW; Copel JA; Macones GA; Menard MK; Riley L; Saade GR
Obstet Gynecol; 2011 Jun; 117(6):1408-1412. PubMed ID: 21471853
[TBL] [Abstract][Full Text] [Related]
19. Utilization, Cost, and Outcome of Branded vs Compounded 17-Alpha Hydroxyprogesterone Caproate in Prevention of Preterm Birth.
Fried I; Beam AL; Kohane IS; Palmer NP
JAMA Intern Med; 2017 Nov; 177(11):1689-1690. PubMed ID: 28973537
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy duration with use of 17-α-hydroxyprogesterone caproate in a retrospective cohort at high risk of recurrent preterm birth.
Massa K; Childress K; Vricella LK; Boerrigter A; Franklin BHK; Sauer M; Armbruster R; Tomlinson T
Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100219. PubMed ID: 33345927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
